Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective study.
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.